SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 13.12 |
Enterprise Value ($M) | 7.25 |
Book Value ($M) | 4.24 |
Book Value / Share | 0.29 |
Price / Book | 3.09 |
NCAV ($M) | 2.54 |
NCAV / Share | 0.17 |
Price / NCAV | 5.17 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -3.46 |
Return on Assets (ROA) | -0.85 |
Return on Equity (ROE) | -1.39 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.67 |
Current Ratio | 1.67 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 8.01 |
Assets | 9.72 |
Liabilities | 5.47 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -19.13 |
Net Income | -18.62 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -18.85 |
Cash from Investing | 9.83 |
Cash from Financing | 9.06 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Ayrton Capital LLC | 7.90 | ||
13G/A | CVI Investments, Inc. | 4.90 | -37.57 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
10,072 | 35,806 | 28.13 | |
15,943 | 34,918 | 45.66 | |
8,460 | 21,715 | 38.96 | |
12,564 | 25,166 | 49.92 | |
(click for more detail) |
Similar Companies | |
---|---|
IMCC – IM Cannabis Corp. | IMMX – Immix Biopharma, Inc. |
IMNM – Immunome, Inc. | IMTX – Immatics N.V. |
INAB – IN8bio, Inc. |
Financial data and stock pages provided by
Fintel.io